Australia Biotechnology Group (ABG) is a prominent health and wellness company, headquartered in Australia with a global presence across Asia, the Middle East, Europe, and North America. Specializing in research, development, manufacturing, and supply of high-quality natural health products, ABG is committed to enriching the lives and health of people worldwide. With 76 Australian TGA listed products and plans to triple this figure in the near future, ABG has established a robust portfolio of pharmaceutical-grade products in various health categories, underpinned by the latest scientific evidence.
Emphasizing the importance of strict quality standards, ABG operates in adherence to the Australian Therapeutic Goods Administration regulations and prioritizes the use of Australian-made ingredients. By maintaining a focus on safety and efficacy, ABG has built a proven track record in providing top-notch health solutions. The company's mission is to leverage the power of nature and deliver products that promote a happier, healthier, and more active lifestyle for consumers worldwide.
As a company founded in 2018, Australia Biotechnology Group believes in fostering well-being and enhancing the quality of life through its commitment to research, development, manufacturing, and marketing of natural healthcare products. With its strong conviction that nature holds the key to addressing many of today’s healthcare challenges, ABG is poised to continue its expansion and impact in the global health and wellness industry.
There is no investment information
No recent news or press coverage available for Australia Biotechnology Group.